Integrated Genetics fertility hormone research
Executive Summary
Company has cloned two hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH) and produced LH utilizing recombinant DNA technology. The firm cloned and produced human chorionic gonadotropin (hCG) last November. Under a 1981 agreement with Serono, Integrated Genetics will manufacture the hormones and Serono will conduct testing, submit DNAs to FDA and hold worldwide sales and marketing rights. Serono, the U.S. leader in fertility drugs, markets the natural hormones as Pergonal (LH and FSH) and Profasi (hCG).
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.